Clinical updates, including trial initiations, enrollment status and data readouts and publications: Achieve, Adagene, Alentis, Allovir, Alucent, Anebulo, Arrowhead, Avenge, Biocryst, Biomarin, Cerevance, Cyclo, Day One, Gaba, IGM, IO, Jacobio, Legacy, Maggie's Pearl, Morphosys, Myrtelle, Neuroderm, Ocuphire, Poolbeg, Shanton, Small, Sorrento, Spexis, Theriva, Trevena, Viking, Viracta, Viridian.